| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 197.13 | 0.1% | 17.3% |
| Total Income | 197.13 | 0.1% | 17.3% |
| Expenditure | 160.26 | 2.9% | 15.4% |
| PBT | 22.88 | 1.0% | 85.4% |
| Net Profit | 13.14 | 6.0% | 98.2% |
| OPM | 12.85% | 0.21pp | 4.07pp |
| NPM | 6.67% | 0.38pp | 2.72pp |
| EPS | 0.48 | 17.2% | 23.1% |
U.S. Physical Therapy Reports Third Quarter 2025 Results
04 May 2026 · 4 May, 8:02 am
Summary
U.S. Physical Therapy reported its Third Quarter 2025 results on November 5, 2025. Adjusted EBITDA increased by 13.2% to $23.9 million compared to the same period last year. Net income attributable to USPH shareholders was $13.1 million, up from $6.6 million in the prior year. Total revenue from physical therapy operations increased by 17.8% to $168.1 million. Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million.
Key Highlights
- 1
Adjusted EBITDA was $23.9 million for the three months ended September 30, 2025, an increase of 13.2% from $21.1 million for the three months ended September 30, 2024.
- 2
Net income attributable to USPH shareholders was $13.1 million for the 2025 Third Quarter compared to $6.6 million for the 2024 Third Quarter.
- 3
Total revenue from physical therapy operations for the 2025 Third Quarter increased 17.8% to $168.1 million from $142.7 million for the 2024 Third Quarter.
- 4
IIP revenue was $29.0 million for the 2025 Third Quarter, an increase of 14.6% as compared to the 2024 Third Quarter.
- 5
The company added 18 and closed seven owned and/or managed clinics in the 2025 Third Quarter, bringing its total count to 779 as of September 30, 2025, compared to 700 as of September 30, 2024.
- 6
Management reaffirmed its full-year 2025 Adjusted EBITDA guidance range of $93.0 million to $97.0 million.
- 7
The Company’s Board of Directors declared a quarterly dividend of $0.45 per share payable on December 12, 2025, to shareholders of record on November 17, 2025.
Management Comments
Chris Reading
This was a very solid quarter for us across the board with record visits per clinic per day, continued clinic expansion with 84 net owned additions since the third quarter of 2024, and sustained double-digit growth in our injury prevention business. Importantly, we are also making progress on some key initiatives that will benefit our 2026 growth and performance, along with an expected and overdue Medicare pricing lift.”
Informational and educational content only. Not investment advice.